Catalyst Wire Dossier Catalyst Wire Dossier

Daratumumab

daratumumab · Janssen Biotech, Inc. (in collaboration with Genmab)
Drug timelines are a Plus or Pro feature.

146 regulatory and trial events tracked for Daratumumab, covering 2017-02-02 to 2026-06-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment [Phase 3]

See pricing